Should Marijuana Stock Investors Rejoice After Aphria’s (TSX:APHA) Surprise Earnings Beat?

After a surprise earnings beat, Aphria Inc (TSX:APHA)(NYSE:APHA) turned bullish. Other marijuana stocks soon to follow?

question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

In a recent article, I opined that Aphria Inc (TSX:APHA)(NYSE:APHA) may be a better buy than Aurora Cannabis Inc due to its faster growth and better profitability track record.

This month, Aphria did indeed outperform Aurora, owing to its strong Q4 earnings report–which virtually nobody expected.

The report, which showed positive net income and adjusted EBITDA, exceeded analyst expectations on just about every metric.

In addition to the aforementioned profits, the company also revealed that it had grown sales at 900% year-over-year, an unbelievable figure even for the high-growth cannabis industry.

Since releasing its Q4 report, Aphria has risen over 33%. The question investors need to ask themselves is whether the company can maintain those gains. To answer that question, we first need to look at that Q4 report in more detail.

Aphria becomes profitable

Aphria wowed market watchers in Q4, which showed even better revenue growth than in the prior quarter (969% year over year, to be precise). However, that stunning growth was not the main highlight of Aphria’s income statement.

What was even more incredible was the company’s profit metrics, which included $15.8 million in net income, $0.2 million in adjusted EBITDA, and $1.9 million in adjusted EBITDA from operations.

These metrics reveal Aphria to have been profitable in the fourth quarter, not only in net, but also in operating terms, making it one of the first large cap marijuana companies to become truly profitable.

Recreational sales way up

Another encouraging metric from Aphria’s Q4 report was recreational sales, which soared 158% from the prior quarter. In the previous quarter, Aphria’s recreational sales tanked by 35%, raising doubts about whether the company was equipped to thrive in the era of legal weed.

Now that the company’s adult-use sales are soaring, it’s beginning to look like the Q3 miss was a one-time problem, not the start of a long term trend.

Other cannabis stocks to follow?

After Aphria’s surprise Q4 earnings beat, it’s natural to wonder whether other marijuana producers will replicate the feat. For a very long time, profits have been a sore spot in the high-growth marijuana industry, with many producers’ losses growing just as quickly as their sales.

It’s hard to say what the future holds, but my best guess is that other marijuana stocks won’t become profitable as quickly as Aphria did. While many large cap producers have posted positive net income before, these results mainly came from financial changes (i.e., fair value adjustments) rather than operating results.

In terms of cash from operations, Canopy Growth and Aurora were both losing money in their most recent quarters. While both of these companies are rapidly increasing their international footprints, that growth comes at a significant financial cost.

Right now, it looks like Aphria is the only large weed company that can keep it lean enough to be profitable.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »